Age and fast initial response predict omalizumab retreatment in chronic urticaria

J Allergy Clin Immunol Pract. 2023 Nov;11(11):3556-3558.e1. doi: 10.1016/j.jaip.2023.07.030. Epub 2023 Jul 28.

¹ Urticaria Centre of Excellence and Reference (UCARE), Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
² Urticaria Centre of Excellence and Reference (UCARE), Department of Dermatology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.
³ Urticaria Centre of Excellence and Reference (UCARE), Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: h.rockmann@umcutrecht.nl.

No abstract available

MeSH terms